Tramadol Hydrochloride
Product Images NDC 21695-699

7 FDA label images from Rebel Distributors Corp. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 21695-699). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (699)

Package Label (699)
Packaging label for Tramadol HCl 100 mg extended-release (ER) tablets, quantity of 30, by Physician Partner, a division of Rebel Distributors Corp. The label includes the NDC 21695-699-30, Product ID RT069930, and indicates the tablets are round, white to off-white, imprinted with 'Par 821'. Manufacturer is Par Pharmaceutical Companies, Inc. The label also notes storage instructions and cautions to keep out of reach of children.*
FDA Label Image

Package Label (700)

Package Label (700)
This is a packaging label for Tramadol HCl 200 mg ER Tablets, 30 count, a prescription medication labeled by Rebel Distributors Corp. The label shows the product ID RT070030 and mentions Par Pharmaceutical Companies, Inc. as the manufacturer. It includes storage instructions and cautions to keep the medication out of children's reach. The label features barcodes and peel tabs with lot and expiration date placeholders.*
FDA Label Image

Figure2a (Fig2a)

Figure2a (Fig2a)
A line graph comparing plasma concentration over time (0 to 24 hours) for two formulations of tramadol: Tramadol HCl ER Tablet 200 mg and Tramadol HCl Tablet 50 mg. The graph shows plasma concentration (ng/mL) on the y-axis and time (hours) on the x-axis, illustrating the pharmacokinetic profiles of the two dosage forms.*
FDA Label Image

Figure2b (Fig2b)

Figure2b (Fig2b)
A line graph comparing the plasma concentration of Tramadol Hydrochloride over time in hours following administration of 200 mg twice daily versus 100 mg twice daily oral tablets. The y-axis shows plasma concentration in ng/mL, and the x-axis represents time in hours over a 24-hour period.*
FDA Label Image

Figure3 (Fig3)

Figure3 (Fig3)
A line graph illustrating the percentage of patients achieving various levels of response threshold in a Tramadol HCl ER tablets study. The x-axis represents the response threshold as percent improvement from baseline, while the y-axis shows the percent of patients achieving response. Multiple lines compare different doses of Tramadol HCl ER tablets (100 mg, 200 mg, 300 mg, 400 mg) and placebo.*
FDA Label Image

Figure4 (Fig4)

Figure4 (Fig4)
A line graph titled 'Tramadol HCl ER Tablets Study 015 Arthritis Intensity VAS Responder Analysis' showing the percent of patients achieving various response thresholds in percent improvement from baseline. Two lines compare Tramadol HCl ER Tablets to placebo, with the x-axis showing response threshold and the y-axis showing percent of patients achieving response.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Tramadol Hydrochloride showing its molecular components, including the methoxyphenyl group, hydroxyl group, cyclohexane ring, and dimethylaminoethyl side chain with hydrochloride indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.